VINCI PHARMACEUTICALS
Live / Applied — Fourth extension granted (statement of use) (as of 15 Jan 2026)
What this means for you
Not registered yet, but its 30 Jun 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98066500
- Mark type
- Stylized text
- Filed
- 30 Jun 2023
- Published for opposition
- 19 Dec 2023
- Attorney of record
- Susan Neuberger Weller
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of retinal diseases
- Class 042 — Scientific and technological services: research and development services in the field of retinal diseases; conducting clinical trials for others in the field of retinal diseases
Owner
- Vinci Pharmaceuticals, Inc., Avon by the Sea, NJ, US
- Vinci Pharmaceuticals, Inc., Avon by the Sea, NJ, US
Prosecution history
- 16 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Jan 2026 — SOU EXTENSION 4 GRANTED
- 15 Jan 2026 — SOU EXTENSION 4 FILED
- 15 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 23 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 May 2025 — SOU EXTENSION 3 GRANTED
- 22 May 2025 — SOU EXTENSION 3 FILED
- 22 May 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Jan 2025 — SOU EXTENSION 2 GRANTED
- 13 Jan 2025 — SOU EXTENSION 2 FILED
- 13 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 24 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Jul 2024 — SOU EXTENSION 1 GRANTED
- 19 Jul 2024 — SOU EXTENSION 1 FILED